Wilmington, DE · Founded 2017 · Privately Held (backing)
Developer of a pharmacological platform designed to treat obesity and its related chronic diseases through targeted small-molecule therapies. Eolo Pharma is based in Wilmington, DE and was founded in 2017. Its last reported valuation was $18 million in Sep 2022. It has raised $7.7 million.
Last reported valuation
$18.0M
Oct 2026
Priced at
—
Total raised
$7.7M
Last round
—
Cap table — not yet on record
Eolo Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Eolo Pharma with a free account
·Watch Eolo Pharma: the Monday email on marks, rounds and moves
